032566784	032566784	CD	B-NP	O
|	|	NN	I-NP	O
LHC	LHC	NN	I-NP	O
|	|	NN	I-NP	O
32147963	32147963	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9021346	9021346	CD	B-NP	O
|	|	CC	I-NP	O
10/22/2003	10/22/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
Hereditary	Hereditary	NNP	I-NP	I-protein
angioedema	angioedema	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/10/2003	10/10/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/10/2003	10/10/2003	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-NP	O
JUREK	JUREK	NN	I-NP	B-protein
,	,	,	O	O
SAMUEL	SAMUEL	NNP	B-NP	O
A.	A.	NNP	I-NP	O
882-12-27-0	882-12-27-0	CD	I-NP	O
Nard	Nard	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
5/30/03	5/30/03	CD	B-NP	O
AT	AT	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
HO	HO	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
WILL	WILL	MD	B-VP	O
D/C	D/C	NNP	B-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MANHART	MANHART	NNP	B-NP	O
,	,	,	O	O
JUAN	JUAN	NNP	B-NP	O
RICARDO	RICARDO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ASA	ASA	NNP	B-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
81	81	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/30/03	5/30/03	CD	B-NP	O
by	by	IN	B-PP	O
DULAR	DULAR	NN	B-NP	B-protein
,	,	,	O	O
LAZARO	LAZARO	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DEFINITE	DEFINITE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
G6PD	G6PD	NN	B-NP	O
DEFICIENCY	DEFICIENCY	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
on	on	IN	B-PP	O
as	as	IN	B-PP	O
outpt	outpt	JJ	B-NP	B-DNA
ATENOLOL	ATENOLOL	NN	I-NP	I-DNA
75	75	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QD	QD	NNP	I-NP	I-DNA
DANAZOL	DANAZOL	NNP	I-NP	I-DNA
200	200	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
TID	TID	NNP	I-NP	I-DNA
Starting	Starting	NNP	I-NP	I-DNA
Today	Today	NNP	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
9/19	9/19	CD	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
Instructions	Instruction	NNPS	I-NP	I-DNA
:	:	:	O	O
For	For	IN	B-PP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
then	then	RB	B-ADVP	O
,	,	,	O	O
200	200	CD	B-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
for	for	IN	B-PP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
alternating	alternate	VBG	B-VP	O
200	200	CD	B-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
and	and	CC	O	O
200	200	CD	B-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
thereafter	thereafter	RB	B-ADVP	O
.	.	.	O	O

DIGOXIN	DIGOXIN	NN	B-NP	O
0.125	0.125	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QOD	QOD	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
0.125	0.125	CD	B-NP	O
on	on	IN	B-PP	O
ttss	ttss	NN	B-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
MWF	MWF	NN	B-NP	O
take	take	NN	I-NP	O
one	one	CD	B-NP	O
and	and	CC	I-NP	O
half	half	NN	I-NP	O
tabs	tab	NNS	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/30/03	5/30/03	CD	B-NP	O
by	by	IN	B-PP	O
SNOOK	SNOOK	NNP	B-NP	B-protein
,	,	,	O	O
OMER	OMER	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	VB	B-VP	O
on	on	RP	B-PRT	O
as	as	IN	B-PP	O
oupt	oupt	JJ	B-NP	O
SYNTHROID	SYNTHROID	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
50	50	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
5/30/03	5/30/03	CD	B-NP	O
by	by	IN	B-PP	O
MAXAM	MAXAM	NN	B-NP	B-protein
,	,	,	O	O
DEVIN	DEVIN	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
DIGOXIN	DIGOXIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
98507267	98507267	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	VB	B-VP	O
on	on	RP	B-PRT	O
as	as	IN	B-PP	O
oupt	oupt	JJ	B-NP	B-DNA
ALLEGRA	ALLEGRA	NN	I-NP	I-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
FEXOFENADINE	FEXOFENADINE	NN	I-NP	I-DNA
HCL	HCL	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
60	60	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
BID	BID	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

DIET	DIET	NN	B-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
wheat	wheat	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
dairy	dairy	NN	I-NP	B-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
FDI	FDI	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
ACTIVITY	ACTIVITY	NNP	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
ambulation	ambulation	NN	I-NP	O
c	c	NN	I-NP	O
walker	walker	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Gallusser	Gallusser	NNP	I-NP	O
please	please	NN	I-NP	O
call	call	VBP	B-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
follow	follow	NN	I-NP	O
up	up	RP	B-PRT	O
appt	appt	NN	B-NP	O
this	this	DT	B-NP	O
afternoon	afternoon	NN	I-NP	O
or	or	CC	I-NP	O
tomorrwow	tomorrwow	NN	I-NP	O
-	-	HYPH	O	O
176-180-1240	176-180-1240	CD	B-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Gerardo	Gerardo	NNP	I-NP	O
Malcome	Malcome	NNP	I-NP	O
please	please	NN	I-NP	O
call	call	VBP	B-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
follow	follow	NN	I-NP	O
up	up	RP	B-PRT	O
appointment	appointment	NN	B-NP	O
this	this	DT	B-NP	O
afternoon	afternoon	NN	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
next	next	JJ	B-NP	O
week	week	NN	I-NP	O
to	to	TO	B-VP	O
check	check	VB	I-VP	O
you	you	PRP	B-NP	O
blood	blood	NN	B-NP	O
-	-	HYPH	B-ADJP	O
417-700-1919	417-700-1919	CD	B-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Iv	Iv	NN	B-NP	O
contrast	contrast	NN	I-NP	O
dyes	dye	NNS	I-NP	O
,	,	,	O	O
Sulfa	Sulfa	NNP	B-NP	O
,	,	,	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
Quinidine	Quinidine	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
quinidine	quinidine	NN	I-NP	O
sulfate	sulfate	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Levofloxacin	Levofloxacin	NNP	B-NP	O
,	,	,	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
,	,	,	O	O
Quinidine	Quinidine	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
quinidine	quinidine	NN	I-NP	O
sulfate	sulfate	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
Macrodantin	Macrodantin	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
nitrofurantoin	nitrofurantoin	NN	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
,	,	,	O	O
Stanazol	Stanazol	NNP	B-NP	O
,	,	,	O	O
Novocain	Novocain	NNP	B-NP	O
1	1	CD	I-NP	O
%	%	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
procaine	procaine	NN	I-NP	O
hcl	hcl	NN	I-NP	O
1	1	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NNP	B-NP	O
,	,	,	O	O
Dairy	Dairy	NNP	B-NP	O
products	product	NNS	I-NP	O
,	,	,	O	O
Wheat/gluten	Wheat/gluten	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Hereditary	Hereditary	NNP	B-NP	O
Angioedema-exacerbation	Angioedema-exacerbation	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Hereditary	Hereditary	NNP	I-NP	O
angioedema	angioedema	NN	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
HEREDITARY	HEREDITARY	NNP	I-NP	O
ANGIOEDEMA	ANGIOEDEMA	NNP	I-NP	O
AFIB	AFIB	NNP	I-NP	O
-	-	HYPH	B-NP	O
lodose	lodose	JJ	I-NP	O
Coum/ASA	Coum/ASA	NN	I-NP	O
HYPOTHY	HYPOTHY	NN	I-NP	O
H/O	H/O	NN	I-NP	O
SUBDURAL	SUBDURAL	NN	I-NP	O
ON	ON	NN	I-NP	O
COUM	COUM	NN	I-NP	O
S/P	S/P	NN	I-NP	O
APPY	APPY	NN	I-NP	O
,	,	,	O	O
TAH	TAH	NN	B-NP	B-protein
tracheostomies	tracheostomy	NNS	I-NP	I-protein
x	x	SYM	O	I-protein
3	3	CD	B-NP	I-protein
multiple	multiple	JJ	I-NP	O
intubations	intubation	NNS	I-NP	O
DVT	DVT	NN	I-NP	O
,	,	,	O	O
ivc	ivc	NN	B-NP	O
filter	filter	NN	I-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
MI	MI	NN	I-NP	O
CAF	CAF	NN	I-NP	O
S/P	S/P	NN	I-NP	O
DVT	DVT	NN	I-NP	O
c	c	NN	I-NP	O
IVC	IVC	NN	I-NP	O
filter	filter	NN	I-NP	O
Hypercholesterolemia	Hypercholesterolemia	NNP	I-NP	O
HTN	HTN	NN	I-NP	O
Hypotension	Hypotension	NNP	I-NP	O
Polycythemia	Polycythemia	NNP	I-NP	O
GERD	GERD	NNP	I-NP	O
polycythemia	polycythemia	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
units	unit	NNS	I-NP	O
FFP	FFP	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
81	81	CD	B-NP	O
y/o	y/o	NN	I-NP	O
womanc	womanc	NN	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
medical	medical	JJ	I-NP	O
problems	problem	NNS	I-NP	O
including	include	VBG	B-PP	O
CAD	CAD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
2	2	CD	B-NP	O
mi	mi	NN	I-NP	O
and	and	CC	O	O
Hereditary	Hereditary	JJ	B-NP	O
angioedema	angioedema	NN	I-NP	O
admitted	admit	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	B-DNA
c	c	NN	I-NP	I-DNA
c/o	c/o	NN	I-NP	I-DNA
,	,	,	O	O
n	n	NN	B-NP	O
,	,	,	O	O
v	v	NN	B-NP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
tenderness	tenderness	NN	I-NP	O
and	and	CC	I-NP	O
chest	chest	NN	I-NP	O
discomfort	discomfort	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
identify	identify	VB	I-VP	O
any	any	DT	B-NP	O
precipitant	precipitant	JJ	I-NP	O
to	to	TO	B-PP	O
what	what	WP	B-NP	O
she	she	PRP	B-NP	O
called	call	VBD	B-VP	O
exacerbation	exacerbation	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
Her	Her	NN	I-NP	B-protein
.	.	.	O	O

Angioedema	Angioedema	NNP	B-NP	O
-	-	HYPH	I-NP	O
No	No	NNP	I-NP	O
sob	sob	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
DOE	DOE	NNP	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
radiations.No	radiations.No	NN	I-NP	B-protein
BRBPR	BRBPR	NN	I-NP	I-protein
,	,	,	O	O
no	no	DT	B-NP	O
incontinence	incontinence	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
with	with	IN	B-PP	O
lopressor	lopressor	NN	B-NP	O
and	and	CC	I-NP	O
SLNT	SLNT	NN	I-NP	B-protein
c	c	NN	I-NP	I-protein
minimal	minimal	JJ	I-NP	I-protein
relief	relief	NN	I-NP	I-protein
.	.	.	O	O

EXAM	EXAM	NN	B-NP	O
-	-	HYPH	I-NP	O
LCTA	LCTA	NN	I-NP	B-protein
,	,	,	O	O
nl	nl	NN	B-NP	B-protein
s1s2	s1s2	NN	I-NP	I-protein
,	,	,	O	O
afib	afib	NN	B-NP	O
,	,	,	O	O
diffuse	diffuse	JJ	B-NP	O
abd	abd	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
,	,	,	O	O
guaic	guaic	JJ	B-ADJP	O
-	-	HYPH	O	O
,	,	,	O	O
Labs	Lab	NNPS	B-NP	B-protein
-	-	HYPH	B-NP	O
LFT	LFT	NN	I-NP	B-protein
wnl	wnl	NN	I-NP	I-protein
,	,	,	O	O
Cardiac	Cardiac	JJ	B-NP	O
enzymes-neg	enzymes-neg	NN	I-NP	O
.	.	.	O	O

Baseline	Baseline	NNP	B-NP	O
Hct	Hct	NNP	I-NP	O
and	and	CC	O	O
Cr	Cr	NNP	B-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	O
neg	neg	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
changes	change	NNS	I-NP	O
on	on	IN	B-PP	O
EKG	EKG	NN	B-NP	B-protein
.	.	.	O	O

t	t	NN	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
of	of	IN	B-PP	O
Hereditary	Hereditary	JJ	B-NP	O
angiodedem	angiodedem	NN	I-NP	O
and	and	CC	O	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
FFP	FFP	NN	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
responded	respond	VBD	B-VP	O
well	well	RB	B-ADVP	O
and	and	CC	O	O
reported	report	VBD	B-VP	O
a	a	DT	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
sx	sx	NN	B-NP	O
of	of	IN	B-PP	O
n	n	NN	B-NP	O
,	,	,	O	O
v	v	NN	B-NP	O
,	,	,	O	O
d.	d.	VBN	B-VP	O
on	on	IN	B-PP	O
8/13	8/13	CD	B-NP	O
she	she	PRP	B-NP	O
cont	cont	VBP	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
mild	mild	JJ	B-NP	O
diffuse	diffuse	JJ	I-NP	O
abd	abd	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
diarrhea	diarrhea	NN	B-NP	O
.	.	.	O	O

ALLERGY	ALLERGY	NNP	B-NP	O
Allergy	Allergy	NNP	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
determined	determine	VBN	B-VP	O
the	the	DT	B-NP	O
likely	likely	JJ	I-NP	O
etiology	etiology	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
her	her	PRP	B-NP	O
Hereditary	Hereditary	NNP	I-NP	O
Angioedema	Angioedema	NNP	I-NP	O
and	and	CC	O	O
changed	change	VBD	B-VP	O
her	her	PRP$	B-NP	O
Danazol	Danazol	NN	I-NP	O
regiment	regiment	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
see	see	VBP	B-VP	O
d/c	d/c	NN	B-NP	O
instruction	instruction	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

CAD	CAD	NN	B-NP	B-protein
-	-	HYPH	O	O
Due	Due	JJ	B-PP	O
to	to	TO	I-PP	O
her	her	PRP$	B-NP	O
reports	report	NNS	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
discomfort	discomfort	NN	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
drawn	draw	VBN	I-VP	O
and	and	CC	O	O
all	all	DT	B-NP	O
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
-	-	HYPH	B-NP	O
not	not	RB	B-VP	O
indicating	indicate	VBG	I-VP	O
cardiac	cardiac	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
and	and	CC	I-NP	O
pt	pt	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
complain	complain	VB	I-VP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
discomfort	discomfort	NN	I-NP	O
or	or	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
after	after	IN	B-SBAR	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
To	To	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Flether	Flether	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
allergy	allergy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
to	to	TO	I-VP	O
call	call	VB	I-VP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
-	-	HYPH	O	O
She	She	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
cont	cont	VB	I-VP	O
.	.	.	O	O

her	her	PRP$	B-NP	O
Danazol	Danazol	NN	I-NP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
Allergy	Allergy	NNP	B-NP	O
recommendations-see	recommendations-see	JJ	I-NP	O
d/c	d/c	NN	I-NP	O
sheet	sheet	NN	I-NP	O
-	-	HYPH	O	O
To	To	TO	B-VP	O
Follow	Follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
PCP	PCP	NN	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Monsay	Monsay	NNP	I-NP	O
for	for	IN	B-PP	O
monitoring	monitoring	NN	B-NP	O
of	of	IN	B-PP	O
CK	CK	NN	B-NP	B-protein
and	and	CC	O	O
LFT	LFT	NN	B-NP	O
's	's	POS	B-NP	O
-	-	HYPH	I-NP	O
Pt	Pt	NN	I-NP	O
to	to	TO	B-VP	O
call	call	VB	I-VP	O
for	for	IN	B-PP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
appointment	appointment	NN	B-NP	O
-	-	HYPH	B-VP	O
No	No	DT	B-NP	O
dictated	dictate	VBN	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
DUSING	DUSING	NNP	B-NP	O
,	,	,	O	O
DONTE	DONTE	NNP	B-NP	O
G.	G.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SR137	SR137	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5/30/03	5/30/03	CD	I-NP	O
@	@	SYM	B-NP	O
02	02	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

